Changes in healthcare resource use and costs associated with early versus delayed initiation of atypical antipsychotic adjunctive treatment in major depressive disorder

Depressive Disorder ◽

Atypical Antipsychotic ◽

Resource Use ◽

Healthcare Resource ◽

Adjunctive Treatment ◽

Healthcare Resource Use ◽

Major Depressive ◽

Delayed Initiation

Healthcare resource use and cost associated with timing of pharmacological treatment for major depressive disorder in the United States: a real-world study

Current Medical Research and Opinion ◽

10.1080/03007995.2019.1652053 ◽

2019 ◽

Vol 35 (12) ◽

pp. 2169-2177

Author(s):

Roger S. McIntyre ◽

Rita Prieto ◽

Patricia Schepman ◽

Yu-Chen Yeh ◽

Matthieu Boucher ◽

...

Keyword(s):

United States ◽

Depressive Disorder ◽

Resource Use ◽

Real World ◽

Pharmacological Treatment ◽

Healthcare Resource ◽

The United States ◽

Healthcare Resource Use ◽

Characteristics and Healthcare Resource use of Patients with Major Depressive Disorder Initiated on Snri Compared to Ssri In Beijing China

Value in Health ◽

10.1016/j.jval.2015.09.998 ◽

2015 ◽

Vol 18 (7) ◽

pp. A414

Author(s):

Y Chen ◽

L Yue ◽

Q Shi ◽

Q Liu ◽

W Montgomery

Keyword(s):

Depressive Disorder ◽

Resource Use ◽

Healthcare Resource ◽

Healthcare Resource Use ◽

Major Depressive ◽

Beijing China

Healthcare Resource Use and Costs In Patients With Major Depressive Disorder Switching From A Generic To A Branded Antidepressant

Value in Health ◽

10.1016/j.jval.2017.08.1882 ◽

2017 ◽

Vol 20 (9) ◽

pp. A712

Author(s):

L Ereshefsky ◽

M Touya ◽

A Rubin ◽

C François

Keyword(s):

Depressive Disorder ◽

Resource Use ◽

Healthcare Resource ◽

Healthcare Resource Use ◽

Quality of Life and Healthcare Resource Use in Patients With Major Depressive Disorder In China: Results From the Proact Study

Value in Health ◽

10.1016/j.jval.2018.07.581 ◽

2018 ◽

Vol 21 ◽

pp. S77

Author(s):

G Wang ◽

KH Tan ◽

C Liu ◽

S Luo ◽

L Hammer-Helmich

Keyword(s):

Quality Of Life ◽

Depressive Disorder ◽

Resource Use ◽

Healthcare Resource ◽

Healthcare Resource Use ◽

Changes in Healthcare Resource use and Costs Associated with the use of Adjunctive Atypical Antipsychotics In Major Depressive Disorder

Value in Health ◽

10.1016/j.jval.2018.04.1265 ◽

2018 ◽

Vol 21 ◽

pp. S186

Author(s):

A Seetasith ◽

M Greene ◽

A Hartry ◽

C Burudpakdee

Keyword(s):

Depressive Disorder ◽

Resource Use ◽

Atypical Antipsychotics ◽

Healthcare Resource ◽

Healthcare Resource Use ◽

Quetiapine - adjunctive treatment of Major depressive disorder with anxiety symptoms

10.26226/morressier.5971be83d462b80290b53094 ◽

2017 ◽

Author(s):

Srebrenka Bise

Keyword(s):

Depressive Disorder ◽

Anxiety Symptoms ◽

Adjunctive Treatment ◽

In vitro characterization of buprenorphine, samidorphan, and combinations being developed as an adjunctive treatment for major depressive disorder

10.26226/morressier.5b681765b56e9b005965c56d ◽

2018 ◽

Author(s):

Sokhom Pin ◽

May Fern Toh

Keyword(s):

Depressive Disorder ◽

Adjunctive Treatment ◽

Major Depressive ◽

In Vitro Characterization

PS152. Efficacy and safety of brexpiprazole (OPC-34712) as adjunctive treatment in major depressive disorder: Meta-analysis of two pivotal studies

The International Journal of Neuropsychopharmacology ◽

10.1093/ijnp/pyw043.152 ◽

2016 ◽

Vol 19 (Suppl_1) ◽

pp. 55-55

Keyword(s):

Depressive Disorder ◽

Meta Analysis ◽

Adjunctive Treatment ◽

Efficacy And Safety ◽

Efficacy Outcomes From 3 Clinical Trials of Edivoxetine as Adjunctive Treatment for Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor Treatment

The Journal of Clinical Psychiatry ◽

10.4088/jcp.14m09619 ◽

2016 ◽

Vol 77 (05) ◽

pp. 635-642 ◽

Cited By ~ 5

Author(s):

Susan G. Ball ◽

Margaret B. Ferguson ◽

James M. Martinez ◽

Beth A. Pangallo ◽

E. Serap Monkul Nery ◽

...

Keyword(s):

Clinical Trials ◽

Depressive Disorder ◽

Selective Serotonin Reuptake Inhibitor ◽

Reuptake Inhibitor ◽

Serotonin Reuptake ◽

Selective Serotonin ◽

Adjunctive Treatment ◽

Major Depressive ◽

Inhibitor Treatment

A Randomized, Placebo-Controlled Study of the Efficacy and Safety of Fixed-Dose Brexpiprazole 2 mg/d as Adjunctive Treatment of Adults With Major Depressive Disorder

The Journal of Clinical Psychiatry ◽

10.4088/jcp.17m12058 ◽

2018 ◽

Vol 79 (4) ◽

Cited By ~ 15

Author(s):

Mary Hobart ◽

Aleksandar Skuban ◽

Peter Zhang ◽

Carole Augustine ◽

Claudette Brewer ◽

...

Keyword(s):

Depressive Disorder ◽

Adjunctive Treatment ◽

Fixed Dose ◽

Controlled Study ◽

Efficacy And Safety ◽